What are the indications, timing, technique, contraindications, and follow‑up for inserting a postpartum copper intrauterine device (PPIUCD)?

Postpartum Copper Intrauterine Device (PPIUCD)

Immediate postpartum copper IUD insertion (within 10 minutes of placental delivery) is a safe, effective contraceptive option that should be offered to all postpartum women regardless of medical complexity, with the primary benefit being prevention of unintended pregnancy and short interpregnancy intervals despite higher expulsion rates compared to interval insertion. 1

Indications

PPIUCD is appropriate for virtually all postpartum women, including those with high-risk medical conditions. The copper IUD is US MEC category 1 or 2 for most medical conditions, making it particularly valuable for women with:

• Thromboembolic disease (estrogen contraindicated)
• Cardiac disease (including peripartum cardiomyopathy)
• Sickle cell disease
• Systemic lupus erythematosus
• Chronic hypertension
• Solid organ transplant
• Drug addiction
• Women with preeclampsia, preterm birth, or ICU admission 1

The copper IUD is category 1 even for women with current breast cancer (unlike hormonal methods which are category 4), making it the preferred LARC option in this population. 1

Timing

Optimal timing is within 10 minutes of placental delivery, which yields approximately 10% expulsion rates. 1 The timing categories are:

• <10 minutes after placental delivery: Category 2 (preferred window)
• 10 minutes to <4 weeks postpartum: Category 2
• ≥4 weeks postpartum: Category 1 2

Despite higher expulsion rates with immediate insertion (24% at 6 months vs. 2% with delayed insertion), continuation rates are actually superior with immediate placement (80% vs. 50%) due to access barriers and missed appointments in the delayed group. 1 This means more women ultimately maintain effective contraception with immediate insertion.

Contraindications

Absolute contraindications (Category 4):

• Active infection: chorioamnionitis or untreated STI without test of cure
• Puerperal sepsis or post-septic abortion
• Ongoing postpartum hemorrhage
• Retained placenta requiring manual removal or surgical evacuation
• Known uterine cavity anomaly/distorted cavity
• Wilson disease (copper-specific contraindication)
• Current cervical, endometrial, or gestational trophoblastic malignancy
• Active pelvic inflammatory disease or pelvic tuberculosis
• Purulent cervicitis
• Unexplained vaginal bleeding 1

Key clinical pitfall: Do not insert if there was chorioamnionitis or the placenta required manual removal—delay insertion until infection resolves or uterine cavity integrity is confirmed.

Technique

For Vaginal Delivery:

1. Change to sterile gloves immediately after placental delivery
2. Remove IUD from manufacturer's inserter and cut strings to 10-12 cm (approximately ParaGard string length)
3. Cleanse cervix with betadine or antiseptic solution
4. Visualize cervix using hand or retractor; grasp anterior lip with ring forceps
5. Grasp IUD wings carefully with ring or Kelly placental forceps
6. Pass device through cervix with gentle cervical retraction under direct visualization
7. Palpate uterine fundus abdominally to confirm fundal placement before releasing forceps
8. Release forceps and move laterally to avoid IUD displacement
9. Transabdominal ultrasound may guide insertion and confirm fundal placement 1

Critical technical point: High fundal placement decreases expulsion rates. 1 If ultrasound before discharge shows lower uterine position, repositioning should be performed. 3

For Cesarean Delivery:

1. Place IUD at uterine fundus manually, with ring forceps, or manufacturer's inserter after initiating hysterotomy closure
2. Direct strings into cervix prior to completing hysterotomy closure 1

Evidence note: A randomized trial found dedicated IUD inserters had higher partial expulsion rates (10.8% vs. 5.0%) and lower retention at 6 weeks (72.2% vs. 83.7%) compared to forceps technique, suggesting forceps placement may be superior. 1

Safety Profile

Immediate postpartum insertion does NOT increase:

• Infection risk
• Uterine perforation risk
• Bleeding complications 1

However, be aware: Recent data shows rotated Cu-IUDs (occurring in ~5% of insertions) progress to partial uterine perforation in 33% of cases, though without pregnancy or frequent expulsion. 4 This warrants ultrasound follow-up if device rotation is detected.

Follow-Up

Recommended schedule:

• Ultrasound before hospital discharge to confirm fundal placement and detect malposition 3, 5
• 2 weeks postpartum
• 6 weeks postpartum with ultrasound assessment
• 3 months postpartum with ultrasound 3, 5

At each visit assess for:

• String visibility (strings trimmed to 10-12 cm should not be visible initially; trim at follow-up after uterine involution) 1
• Expulsion symptoms (cramping, device felt/seen)
• Abnormal bleeding or pain
• Ultrasound confirmation of fundal position
• Patient satisfaction and desire to continue

Common side effects: Irregular bleeding and dysmenorrhea occur in approximately 60% of women but do not significantly differ from interval insertion at 1 year. 6 Cu-375 may cause less bleeding and dysmenorrhea than Cu-T 380A. 7

Expulsion rates: Cumulative expulsion ranges from 4-15% depending on timing and technique, with higher rates in preterm deliveries (15.3% at 12 months vs. 6.4% in term). 3, 8 Predictors include higher parity, younger age, and lack of motivation. 3

Critical counseling point: Despite higher expulsion risk, immediate PPIUCD reduces unintended pregnancy rates and short interpregnancy intervals, which directly improves maternal and neonatal morbidity and mortality. 1 The 80% continuation rate at 6 months with immediate insertion versus 50% with delayed insertion means immediate placement results in more women protected from pregnancy. 1